← Leaderboards
Rodica Pop-Busui
University Of Iowa
$6,915,511
Attributed
$13,005,431
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,005,431 · 6
By mechanism
R01$7,796,916 · 3
U01$4,790,017 · 1
R21$340,748 · 1
R03$77,750 · 1
Top collaborators
- Crystal Murray Holmes11 shared
- Katherine Ann Gallagher8 shared
- Kayvan Najarian8 shared
- Eva L Feldman7 shared
- Mark Anthony Yorek4 shared
- Brian M Schmidt2 shared
- James S Wrobel1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Mark Anthony Yorek$7,990,158
- Kathryn G Lamping$485,268
- Christina M Wang$1,790
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusComplications Of Diabetes MellitusAffectClinical ResearchAmputationCostFuturePublic Health RelevanceDesignBaseMortalityNovel TherapeuticsParticipantRisk FactorsMichiganUlcerClinical TrialsCaringUniversitiesChronicInsulin-Dependent Diabetes MellitusMorbidity - Disease RateHealth Care CostsFda Approved
Grant awards (30)
NIDDK Diabetic Foot Consortium Clinical Research Unit$727,080
U01 · FY2025 · DK
Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic Neuropathy$595,517
R01 · FY2025 · DK
NIDDK Diabetic Foot Consortium Clinical Research Unit$727,080
U01 · FY2024 · DK
Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic Neuropathy$631,718
R01 · FY2024 · DK
Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic Neuropathy$648,375
R01 · FY2023 · DK
NIDDK Diabetic Foot Consortium Clinical Research Unit$555,400
U01 · FY2023 · DK · contact PI
NIDDK Diabetic Foot Consortium Clinical Research Unit$199,680
U01 · FY2023 · DK · contact PI
Effects of Fish Oil ± Salsalate on the Omega-3 Index and the Circulating Lipodome of Omega-3 Polyunsaturated Fatty Acid Metabolites in Patients with Type 2 Diabetes and Diabetic Neuropathy$659,283
R01 · FY2022 · DK
DFU Clinical Research Unit$269,358
U01 · FY2022 · DK · contact PI
DFU Clinical Research Unit$542,357
U01 · FY2021 · DK · contact PI
DFU Clinical Research Unit$49,505
U01 · FY2021 · DK · contact PI
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy$471,210
R01 · FY2020 · DK
DFU Clinical Research Unit$429,000
U01 · FY2020 · DK · contact PI
DFU Clinical Research Unit$388,652
U01 · FY2020 · DK · contact PI
DFU Clinical Research Unit$49,505
U01 · FY2020 · DK · contact PI
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy$578,101
R01 · FY2019 · DK
DFU Clinical Research Unit$429,000
U01 · FY2019 · DK · contact PI
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy$579,358
R01 · FY2018 · DK
DFU Clinical Research Unit$423,400
U01 · FY2018 · DK
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy$190,635
R01 · FY2018 · DK
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy$588,280
R01 · FY2017 · DK
Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy$594,488
R01 · FY2016 · DK
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes$431,022
R01 · FY2014 · HL · contact PI
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes$419,367
R01 · FY2013 · HL · contact PI
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes$460,591
R01 · FY2012 · HL · contact PI
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes$476,753
R01 · FY2011 · HL · contact PI
Targeting Inflammation using Salsalate in Type 1 Diabetic Neuropathy (TINSAL-T1DN$77,750
R03 · FY2011 · DK · contact PI
Cardiac Autonomic Neuropathy and Myocardial Dysfunction in Type 1 Diabetes$472,218
R01 · FY2010 · HL · contact PI
Cyclooxygenase Pathway and Diabetic Neuropathy$170,779
R21 · FY2005 · NS
Cyclooxygenase Pathway and Diabetic Neuropathy$169,969
R21 · FY2004 · NS